Given the observed role of PROX1 in modulating tumor growth and that glycolysis is the primary feature of metabolic reprogramming in cancer and is a metabolic signature for highly proliferative cancer, we speculated that PROX1 may promote cell proliferation by affecting glycolysis in colon cancer cells. The gene discussed is PROX1; the disease is malignant colon neoplasm.